Year: 2020

TORTOLA, British Virgin Islands, Nov. 18, 2020 (GLOBE NEWSWIRE) — Orca Energy Group Inc. (“Orca” or “the Company” and includes its subsidiaries and affiliates) (TSX-V: ORC.A, ORC.B) today announces it has filed its condensed consolidated interim financial statements and management’s discussion and analysis for the three and nine month periods ended September 30, 2020 with the Canadian securities regulatory authorities. All amounts are in United States dollars (“$”) unless otherwise stated.On August 3, 2020 the Company signed a contract for installation of compression on the Songas Limited (“Songas”) gas processing facility for a total value of $38 million, of which $13.3 million has been spent to date. Compression is currently planned for installation prior to the end of Q2 2022 and will allow maximum...

VANCOUVER, British Columbia, Nov. 18, 2020 (GLOBE NEWSWIRE) — Pender Growth Fund Inc. (TSXV: PTF) (“PGF” or the “Company”) announces today that, further to its press release dated October 30, 2020, PGF has completed the second and final tranche (the “Final Tranche”) of the share purchase transaction with Bhayana Management Ltd. and The Madan and Raksha M. Bhayana Family Foundation (collectively, the “Vendors”) pursuant to the terms of the Share Purchase Agreement entered into between PGF and the Vendors on October 30, 2020, as amended (the “Purchase Agreement”).PGF today purchased from the Vendors a total of 3,345,881 Class B Subordinated Voting Shares (the “Subordinated Voting Shares”) in the share capital of INSCAPE Corporation (TSX: INQ) (“Inscape”) at the price of $0.65 per Subordinated Voting Share, for an aggregate purchase...

SAN FRANCISCO, Nov. 18, 2020 (GLOBE NEWSWIRE) — Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted therapies for women’s cancers, today announced the pricing of its initial public offering of 11,000,000 shares of its common stock at a price to the public of $19.00 per share. The gross proceeds to Olema Oncology from the offering, before deducting the underwriting discounts and commissions and offering expenses, are expected to be $209.0 million. All of the shares are being offered by Olema Oncology. In addition, Olema Oncology has granted the underwriters a 30-day option to purchase up to an additional 1,650,000 shares of its common stock at the initial public offering price, less the underwriting discounts...

LUXEMBOURG, Nov. 18, 2020 (GLOBE NEWSWIRE) — NeoGames S.A. (Nasdaq: NGMS) (“NeoGames” or the “Company”), a technology-driven provider of end-to-end iLottery solutions, announced today the pricing of its initial public offering of 4,807,522 ordinary shares, consisting of 2,627,061 ordinary shares being offered by the Company and 2,180,461 ordinary shares being offered by certain selling shareholders, at a price of $17.00 per ordinary share. The Company has granted the underwriters a 30-day option to purchase up to an additional 721,128 ordinary shares at the initial public offering price. The shares will be listed on The Nasdaq Global Market and trade under the ticker symbol “NGMS” beginning on November 19, 2020. The offering is expected to close on November 23, 2020, subject to the satisfaction of customary...

TORTOLA, British Virgin Islands, Nov. 18, 2020 (GLOBE NEWSWIRE) — Orca Energy Group Inc. (“Orca” or the “Company”) (TSX-V: ORC.A, ORC.B) today announced that its Board of Directors has declared a quarterly cash dividend of CDN$0.08 per Class A Common Voting Share (“Class A Shares“) of the Company and CDN$0.08 per Class B Subordinate Voting Share (“Class B Shares“) of the Company. The dividend will be payable on January 15, 2021 to holders of Class A Shares and Class B Shares of record on December 31, 2020.Approval of Dividend PolicyThe Board of Directors of the Corporation is pleased to announce the approval of a dividend policy of paying quarterly dividends to holders of Class A Shares and Class B Shares. Dividends will normally be declared when (i) pre-approved by the Board of Directors on a quarterly basis,...

RENO, Nev., Nov. 18, 2020 (GLOBE NEWSWIRE) — Ormat Technologies, Inc. (NYSE: ORA) (“Ormat” or the “Company”), a leading vertically integrated company that is primarily engaged in the geothermal and recovered energy generation (“REG”) businesses, as well the solar photovoltaic (PV) and energy storage and management services business, today announced that it has priced its underwritten public offering of 4,150,000 shares of its common stock at a price of $74.00 per share. The offering is expected to close on November 23, 2020, subject to market and other conditions.Ormat intends to use the net proceeds from the offering for general corporate purposes, including working capital and capital expenditures, and for potential acquisitions, including complementary businesses, technologies or assets.J.P. Morgan Securities LLC and BofA Securities...

CALGARY, Alberta, Nov. 18, 2020 (GLOBE NEWSWIRE) — Quorum Information Technologies Inc. (“Quorum”), a leading provider of innovative and robust technology solutions and services to traditional and electric vehicle dealerships and Original Equipment Manufacturers (“OEM”) across North America, released its results for Q3 2020 today.  Q3 2020 total revenue of $8.1 million was a 36% increase over Q2 2020 as one-time $1.8 million SaaS and BDC COVID-19 discounts Quorum provided to its dealerships were discontinued. Normalized SaaS revenue and BDC revenue without the Q2 COVID-19 discounts would have shown an increase of 2.4% and 4.3% respectively in Q3 over Q2 and puts Quorum back to 9.6% SaaS and 17.2% BDC annual revenue growth rates respectively. Quorum’s SaaS and BDC recurring revenue streams represented 96% of its total Q3 revenue.“We’d...

NEW YORK, Nov. 18, 2020 (GLOBE NEWSWIRE) — Prevail Therapeutics Inc. (Nasdaq: PRVL), a biotechnology company developing potentially disease-modifying AAV-based gene therapies for patients with neurodegenerative diseases, today announced that the United States Patent and Trademark Office (USPTO) on November 17, 2020 issued a composition of matter patent, U.S. Patent No. 10,837,028, with claims directed to the AAV vector used in PR001, Prevail’s experimental gene therapy program for the treatment of Parkinson’s disease with GBA1 mutations (PD-GBA) and neuronopathic Gaucher disease (nGD). The base patent term extends until October 3, 2038, excluding patent term extensions or coverage in additional related patent filings.“We are excited to make important progress this year with PR001, which is being evaluated in the Phase 1/2 PROPEL...

MORRISVILLE, N.C., Nov. 18, 2020 (GLOBE NEWSWIRE) — Syneos Health, Inc. (Nasdaq: SYNH) (the “Company” or “Syneos Health”), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and a CCO (Contract Commercial Organization), today announced the upsizing and pricing of an offering of $600.0 million aggregate principal amount of 3.625% senior notes due 2029 (the “Notes”), an upsize of $100.0 million over the amount previously announced. The Notes were priced at par value and will bear an interest rate of 3.625% per annum. The Notes are being offered in a private offering that is exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”). The Notes will be guaranteed, jointly and severally, on a senior unsecured basis, by certain...